MJ KENNY appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.
Source-backed chronology
Prior government service disclosed in an LDA filing; exact dates not reported
Federal government
Inspect source ↗Documented in an LDA filing dated Jul 17, 2019
Prior government service disclosed in an LDA filing; exact dates not reported
Federal government
Inspect source ↗Federal LDA filings
Registrant: KOUNTOUPES DENHAM CARR & REID, LLC · Pharmacy
General education about the pharmacy benefit manager/pharmacy industry, including spread pricing proposals and S.476, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU)Act. Issues related to Risk Evaluation and Mitigation Strategies (REMS) program, including S.340 and H. R. 965, The CREATES Act. S. 1895, Lower Health Case Costs Act; S.1227, The Prescription Pricing for the People Act of 2019.
LDA filing ↗Registrant: KOUNTOUPES DENHAM CARR & REID, LLC · Health Issues
General education about the pharmacy benefit manager/pharmacy and insurance industry, including S.476, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, S. 1895 Lower Health Care Costs Act, S. 2543, The Prescription Drug Pricing Reduction Act, and H. R. 3, The Lower Drug Costs Now Act. H. R. 3502, the Protecting People from Surprise Medical Bills Act.
LDA filing ↗Registrant: KOUNTOUPES DENHAM CARR & REID, LLC · Pharmacy
General education about the pharmacy benefit manager/pharmacy industry, including spread pricing proposals and S.476, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU)Act. Issues related to Risk Evaluation and Mitigation Strategies (REMS) program. S. 1895, Lower Health Case Costs Act; S.1227, The Prescription Pricing for the People Act of 2019. Issues related to H.R.748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including provisions relating to the drug supply chain.
LDA filing ↗Registrant: KOUNTOUPES DENHAM CARR & REID, LLC · Health Issues
General education about the pharmacy benefit manager/pharmacy and insurance industry, including S.476, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, S. 1895 Lower Health Care Costs Act, S. 2543, The Prescription Drug Pricing Reduction Act, and H. R. 3, The Lower Drug Costs Now Act. H. R. 3502, the Protecting People from Surprise Medical Bills Act.
LDA filing ↗Registrant: KOUNTOUPES DENHAM CARR & REID, LLC · Health Issues
General education about the pharmacy benefit manager/pharmacy industry, including S.476, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act and S. 1895 Lower Health Care Costs Act.
LDA filing ↗Registrant: KOUNTOUPES DENHAM CARR & REID, LLC · Health Issues
General education about the pharmacy benefit manager/pharmacy and insurance industry, including S.476, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, S. 1895 Lower Health Care Costs Act, S. 2543, The Prescription Drug Pricing Reduction Act, and H. R. 3, The Lower Drug Costs Now Act. H. R. 3502, the Protecting People from Surprise Medical Bills Act. Issues related to H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including provisions related to the treatment of patients.
LDA filing ↗Registrant: KOUNTOUPES DENHAM CARR & REID, LLC · Health Issues
General education about the pharmacy benefit manager/pharmacy and insurance industry. Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including provisions related to the treatment of patients. Issues related to surprise billing, including H.R. 3630, No Surprises Act and H.R. 3502, Protecting People From Surprise Medical Bills Act and extension of COBRA benefits. Issues related to H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), including provisions related to testing and vaccines. Issues related to H.R. 133, Consolidated Appropriations Act for Fiscal Year 2021. Issues related to H.R. 1418, Competitive Health Insurance Reform Act, including the repeal of McCarran-Ferguson Act.
LDA filing ↗Registrant: KOUNTOUPES DENHAM CARR & REID, LLC · Pharmacy
General education about the pharmacy benefit manager/pharmacy industry, including S.476, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU)Act. Issues related to Risk Evaluation and Mitigation Strategies (REMS) program, including S.340 and H. R. 965, The CREATES Act. S. 1895, Lower Health Case Costs Act; S.1227, The Prescription Pricing for the People Act of 2019.
LDA filing ↗Registrant: KOUNTOUPES DENHAM CARR & REID, LLC · Pharmacy
General education about the pharmacy benefit manager/pharmacy industry, including spread pricing proposals and S.476, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU)Act. Issues related to Risk Evaluation and Mitigation Strategies (REMS) program, including S.340 and H. R. 965, The CREATES Act. S. 1895, Lower Health Case Costs Act; S.1227, The Prescription Pricing for the People Act of 2019.
LDA filing ↗